Accéder au contenu
Merck

Painting blood vessels and atherosclerotic plaques with an adhesive drug depot.

Proceedings of the National Academy of Sciences of the United States of America (2012-12-14)
Christian J Kastrup, Matthias Nahrendorf, Jose Luiz Figueiredo, Haeshin Lee, Swetha Kambhampati, Timothy Lee, Seung-Woo Cho, Rostic Gorbatov, Yoshiko Iwamoto, Tram T Dang, Partha Dutta, Ju Hun Yeon, Hao Cheng, Christopher D Pritchard, Arturo J Vegas, Cory D Siegel, Samantha MacDougall, Michael Okonkwo, Anh Thai, James R Stone, Arthur J Coury, Ralph Weissleder, Robert Langer, Daniel G Anderson
RÉSUMÉ

The treatment of diseased vasculature remains challenging, in part because of the difficulty in implanting drug-eluting devices without subjecting vessels to damaging mechanical forces. Implanting materials using adhesive forces could overcome this challenge, but materials have previously not been shown to durably adhere to intact endothelium under blood flow. Marine mussels secrete strong underwater adhesives that have been mimicked in synthetic systems. Here we develop a drug-eluting bioadhesive gel that can be locally and durably glued onto the inside surface of blood vessels. In a mouse model of atherosclerosis, inflamed plaques treated with steroid-eluting adhesive gels had reduced macrophage content and developed protective fibrous caps covering the plaque core. Treatment also lowered plasma cytokine levels and biomarkers of inflammation in the plaque. The drug-eluting devices developed here provide a general strategy for implanting therapeutics in the vasculature using adhesive forces and could potentially be used to stabilize rupture-prone plaques.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1,2-Dihydroxybenzene, ReagentPlus®, ≥99%
Sigma-Aldrich
Pyrocatechol, ≥99%
Sigma-Aldrich
Pyrocatechol, purified by sublimation, ≥99.5%